Ru Li

Ru Li

47 year
Health Technology
Consumer Services

Profile

Ru Li currently works at Shanghai Shyndec Pharmaceutical Co., Ltd., as Director from 2022, China National Pharmaceutical Group Co., Ltd., as Deputy Director & Director-Risk & Operation from 2012, Sinopharm Common Wealth Co. Ltd., as Director, Chongqing Taiji Industry (Group) Co., Ltd., as Member-Supervisory Board from 2021, and China National of Traditional & Herbal Medicine Co., Ltd., as Member-Supervisory Board.
Ms. Li also formerly worked at China Traditional Chinese Medicine Holdings Co. Ltd., as Non-Executive Director from 2019 to 2025, Takeda AS, as Market Manager from 2010 to 2012, and China National Medicines Co., Ltd., as Manager-Product, Regional & Divisional Sales from 2001 to 2010.
Ms. Li received her undergraduate degree in 2001 from Shenyang Pharmaceutical University.

Ru Li active positions

CompaniesPositionStart
CHONGQING TAIJI INDUSTRY(GROUP) CO.,LTD Director/Board Member 19/05/2021
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Director/Board Member 28/11/2022
Director/Board Member -
Corporate Officer/Principal 01/01/2012

Former positions of Ru Li

CompaniesPositionEnd
CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO. LIMITED Director/Board Member 15/01/2025
Sales & Marketing 01/01/2012
CHINA NATIONAL MEDICINES CORPORATION LTD. Corporate Officer/Principal 01/01/2010
See the detail of Ru Li's experience

Training of Ru Li

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

41

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!